Trials / Terminated
TerminatedNCT00694967
A Randomized Trial of Cerclage Versus 17 α-Hydroxyprogesterone Caproate for Treatment of a Short Cervix
Histologic Evaluation of the Cervix at Risk for Preterm Birth Trial:Medical Versus Surgical Therapy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Lehigh Valley Hospital · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
We hypothesized that weekly intramuscular injections of 17 hydroxyprogesterone caproate(17P) will reduce the number spontaneous preterm births prior to 35 weeks gestation when compared to cerclage therapy. The purpose of this study was to compare medical therapy with 17P to surgical therapy with transvaginal cerclage in patients with an ultrasound diagnosed short cervix and funnel in the mid-trimester.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | McDonald cerclage placement | Transcervical McDonald cerclage placement |
| DRUG | 17 hydroxyprogesterone caproate | Weekly 250mg intramuscular injections |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2006-12-01
- Completion
- 2006-12-01
- First posted
- 2008-06-11
- Last updated
- 2008-06-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00694967. Inclusion in this directory is not an endorsement.